Transient Pharma AB
559200-7875ActiveDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2019
- Founded
Key Decision Makers
Helene Hartman
CEO and Founder
Christian Kjellman
COO
Artur Schmidtchen
Professor and Founder
Lena Mårtensson
Board member
+4 more contacts in Funnelfeedr
Description
Transient Pharma AB is a privately held, unlisted public company headquartered in Lund, Sweden. Their core mission is developing innovative treatments for diseases driven by excessive inflammation. The company leverages over 15 years of scientific research focused on Thrombin-derived C-terminal pept...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559200787501
Decision Makers
8 contacts in FunnelfeedrHelene Hartman
CEO and Founder
Christian Kjellman
COO
Artur Schmidtchen
Professor and Founder
Lena Mårtensson
Board member
Johan Jensen
Board member
Bo Benell
Chairman
Other Contacts
Anna-Karin Lindqvist
Drug Development Expert
Ganna Petruk
Senior Research Scientist
Similar Companies
20 similar companies in FunnelfeedrPILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
Truly Translational Sweden AB
1–4 employeesAccelerating preclinical drug development through translational expertise and lab services.
Glimworks AB
6 employeesDeveloping complex IT solutions via deep information architecture partnerships.
Truly Labs AB
20–49 employeesAccelerating preclinical drug development through translational expertise and lab services.
AQILION AB
5–9 employeesDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Browse More
Transient Pharma AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo